Medtronic's bone graft linked to surgery complications, FDA warns

09/4/2008 | Wall Street Journal, The

The FDA has received multiple reports during a four-year period of serious problems stemming from the off-label use of Medtronic's Infuse Bone Graft, a biologically engineered liquid used in spine-repair surgeries to aid bone growth. Medtronic said it has informed doctors about the product's possible side effects and emphasized that the complication rate is low.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC